MCAM and Familial prostate cancer: On the other hand, in contrast with several evidences supporting a role for MCAM overexpression in metastatic transformation of various types of tumors including melanoma [58] prostate cancer [59] and non-small-cell lung carcinoma [60], our data would suggest that a reduced expression of MCAM promotes migration.